Wu Yi-chen, an entrepreneur from China's Taiwan region, set up the headquarters of her company's mainland business in Beijing's Changping District. She not only appreciated the local government's "service kit" offered for enterprises' development, but also spoke highly of the academic exchanges and cooperation on cancer and biotechnology research between her company and others on the mainland. "When cross-strait enterprises join hands in biotechnology research and development or clinical research, I believe together we can lead the world," Wu said.